Bacteriophages: an appraisal of their role in the treatment of bacterial infections.
暂无分享,去创建一个
[1] S. Denyer,et al. Reduction in Exopolysaccharide Viscosity as an Aid to Bacteriophage Penetration through Pseudomonas aeruginosa Biofilms , 2001, Applied and Environmental Microbiology.
[2] C. Bloch,et al. Dynamics of success and failure in phage and antibiotic therapy in experimental infections , 2002, BMC Microbiology.
[3] N. Woodford,et al. Multiresistant acinetobacter in the UK: how big a threat? , 2004, The Journal of hospital infection.
[4] C. Merril,et al. Fate of Bacteriophage Lambda in Non-immune Germ-free Mice , 1973, Nature.
[5] M. Dabrowski,et al. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. , 1985, Archivum immunologiae et therapiae experimentalis.
[6] V. Fischetti,et al. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Slotman,et al. A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis , 2000, Journal of endotoxin research.
[8] J. Geiselmann,et al. Control of bacteriophage mu lysogenic repression. , 2005, Journal of molecular biology.
[9] D. Hilbert,et al. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. , 2005, Surgery.
[10] M. D. Eaton,et al. BACTERIOPHAGE THERAPY: REVIEW OF THE PRINCIPLES AND RESULTS OF THE USE OF BACTERIOPHAGE IN THE TREATMENT OF INFECTIONS , 1934 .
[11] M. Cisło,et al. Bacteriophage treatment of suppurative skin infections. , 1987, Archivum immunologiae et therapiae experimentalis.
[12] M. Griffiths,et al. Infection and removal of L-forms of Listeria monocytogenes with bred bacteriophage. , 1997, International journal of food microbiology.
[13] R. Holzheimer. Antibiotic Induced Endotoxin Release and Clinical Sepsis: a Review , 2001, Journal of chemotherapy.
[14] J. Soothill. Treatment of experimental infections of mice with bacteriophages. , 1992, Journal of medical microbiology.
[15] Z. Li,et al. Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth. , 2000, Biochimica et biophysica acta.
[16] I. Wang,et al. Phages will out: strategies of host cell lysis. , 2000, Trends in microbiology.
[17] P. Setlow,et al. Cloning, nucleotide sequencing, and genetic mapping of the gene for small, acid-soluble spore protein gamma of Bacillus subtilis , 1987, Journal of bacteriology.
[18] J. Costerton,et al. Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.
[19] H. Neve,et al. Gene Cloning and Expression and Secretion ofListeria monocytogenes Bacteriophage-Lytic Enzymes inLactococcus lactis , 2000, Applied and Environmental Microbiology.
[20] K. Carlson. Working with bacteriophages: common techniques and methodological approaches , 2005 .
[21] M. Delbrück,et al. THE GROWTH OF BACTERIOPHAGE , 1939, The Journal of general physiology.
[22] C. Merril,et al. Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium , 2002, Infection and Immunity.
[23] K. Iczkowski,et al. Bacteriophages show promise as antimicrobial agents. , 1998, The Journal of infection.
[24] M. Dabrowski,et al. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. , 1983, Archivum immunologiae et therapiae experimentalis.
[25] R. Hoekstra,et al. Dynamics of dsRNA mycoviruses in black Aspergillus populations. , 2006, Fungal genetics and biology : FG & B.
[26] V. Fischetti,et al. Bacteriophage lytic enzymes: novel anti-infectives. , 2005, Trends in microbiology.
[27] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[28] D. Duckworth. "Who discovered bacteriophage?". , 1976, Bacteriological reviews.
[29] K. M. Shaw,et al. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. , 1987, Journal of general microbiology.
[30] S. Ghabrial. Origin, Adaptation and Evolutionary Pathways of Fungal Viruses , 2004, Virus Genes.
[31] Raymond Schuch,et al. A bacteriolytic agent that detects and kills Bacillus anthracis , 2002, Nature.
[32] D. Sosnowska,et al. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. , 2002, The Journal of infectious diseases.
[33] A. Sulakvelidze,et al. Bacteriophage Therapy in Humans , 2004 .
[34] P. Youderian,et al. Biocontrol of Escherichia coli O157 with O157-Specific Bacteriophages , 1999, Applied and Environmental Microbiology.
[35] Paul A. Barrow,et al. Phages and their application against drug‐resistant bacteria , 2001 .
[36] H. Smith,et al. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. , 1982, Journal of general microbiology.
[37] R. Holzheimer. The significance of endotoxin release in experimental and clinical sepsis in surgical patients — Evidence for antibiotic-induced endotoxin release? , 1998, Infection.
[38] J. Sulova,et al. Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327. , 1981, Czechoslovak medicine.
[39] I. Sutherland,et al. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. , 1998, Microbiology.
[40] K. Miyanaga,et al. Toward rational control of Escherichia coli O157:H7 by a phage cocktail , 2004, Applied Microbiology and Biotechnology.
[41] Hajime Unno,et al. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. , 2005, Journal of bioscience and bioengineering.
[42] Alexander Sulakvelidze,et al. Bacteriophages: Biology and Applications , 2007 .
[43] G. Lemay,et al. A glycosyl hydrolase activity of mammalian reovirus sigma1 protein can contribute to viral infection through a mucus layer. , 1999, Journal of molecular biology.
[44] M. Dabrowski,et al. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. , 1987, Archivum immunologiae et therapiae experimentalis.
[45] M. Loessner,et al. Bacteriophage endolysins--current state of research and applications. , 2005, Current opinion in microbiology.
[46] R. Lenski. Dynamics of Interactions between Bacteria and Virulent Bacteriophage , 1988 .
[47] C. Mock,et al. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. , 1995, Archives of surgery.
[48] P. Setlow,et al. Small, acid-soluble proteins bound to DNA protect Bacillus subtilis spores from killing by dry heat , 1995, Applied and environmental microbiology.
[49] Yin-Won Lee,et al. Double-Stranded RNA Mycovirus from Fusarium graminearum , 2002, Applied and Environmental Microbiology.
[50] Wolf-Dietrich Hardt,et al. Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion , 2004, Microbiology and Molecular Biology Reviews.
[51] R. Katsarava,et al. The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug‐resistant Staphylococcus aureus‐infected local radiation injuries caused by exposure to Sr90 , 2005, Clinical and experimental dermatology.
[52] C. Merril,et al. Long-circulating bacteriophage as antibacterial agents. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Buck. From interferon induction to fungal viruses , 1988, European Journal of Epidemiology.
[54] J. Powers,et al. Trends in antimicrobial drug development: implications for the future. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] K. Tait,et al. The efficacy of bacteriophage as a method of biofilm eradication , 2002 .
[56] I. Sutherland,et al. Bacteriophage and associated polysaccharide depolymerases – novel tools for study of bacterial biofilms , 1998, Journal of applied microbiology.
[57] K. M. Shaw,et al. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. , 1987, Journal of general microbiology.
[58] M. Dabrowski,et al. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. , 1984, Archivum immunologiae et therapiae experimentalis.
[59] F. Bautz,et al. The Zygosaccharomyces bailii antifungal virus toxin zygocin: cloning and expression in a heterologous fungal host , 2002, Molecular microbiology.
[60] M. Dabrowski,et al. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. , 1985, Archivum immunologiae et therapiae experimentalis.
[61] P. Setlow,et al. Synthesis of a Bacillus subtilis small, acid-soluble spore protein in Escherichia coli causes cell DNA to assume some characteristics of spore DNA , 1991, Journal of bacteriology.
[62] P. Setlow,et al. Binding to DNA protects alpha/beta-type, small, acid-soluble spore proteins of Bacillus and Clostridium species against digestion by their specific protease as well as by other proteases , 1995, Journal of bacteriology.
[63] J. Wain,et al. The role of prophage-like elements in the diversity of Salmonella enterica serovars. , 2004, Journal of molecular biology.
[64] P. Setlow. Mechanisms for the prevention of damage to DNA in spores of Bacillus species. , 1995, Annual review of microbiology.
[65] R. Katsarava,et al. A novel sustained‐release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds , 2002, International journal of dermatology.
[66] H. Smith,et al. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. , 1983, Journal of general microbiology.
[67] L. Bermudez,et al. In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium. , 2006, Microbial drug resistance.
[68] J. Soothill. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. , 1994, Burns : journal of the International Society for Burn Injuries.
[69] P. Setlow. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals , 2006, Journal of applied microbiology.